Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of Tuesday, October 6, 2026.
EARNINGS PER SHARE (EPS)
N/A
Veraxa Biotech Holding AG
Market Cap
$152.72M
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$153.58M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.05
3Y Avg
-0.06
5Y Avg
-0.06
Market Cap
$153.79M
Earnings Per Share (EPS)
-0.43
TTM Avg
-0.98
3Y Avg
-1.10
5Y Avg
-1.18
Market Cap
$151.01M
Earnings Per Share (EPS)
-0.26
TTM Avg
-0.32
3Y Avg
-0.33
5Y Avg
-0.37
Market Cap
$149.36M
Earnings Per Share (EPS)
-1.13
TTM Avg
-2.24
3Y Avg
-2.81
5Y Avg
-2.43
Market Cap
$156.22M
Earnings Per Share (EPS)
-0.90
TTM Avg
-1.19
3Y Avg
-2.61
5Y Avg
-1.83
Market Cap
$148.73M
Earnings Per Share (EPS)
-12.04
TTM Avg
-8.05
3Y Avg
-55.02
5Y Avg
-123.25
Market Cap
$148.64M
Earnings Per Share (EPS)
-1.81
TTM Avg
-1.58
3Y Avg
-0.32
5Y Avg
-0.34
Market Cap
$148.27M
Earnings Per Share (EPS)
-0.26
TTM Avg
-0.53
3Y Avg
-0.57
5Y Avg
-0.55
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Veraxa Biotech Holding AG (VRXA) | $152.72M | N/A | N/A | N/A | N/A |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $153.58M | N/A | -0.05 | -0.06 | -0.06 |
| Neuronetics, Inc. (STIM)vs › | $153.79M | -0.43 | -0.98 | -1.10 | -1.18 |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.01M | -0.26 | -0.32 | -0.33 | -0.37 |
| ALX Oncology Holdings Inc. (ALXO)vs › | $149.36M | -1.13 | -2.24 | -2.81 | -2.43 |
| Inogen, Inc. (INGN)vs › | $156.22M | -0.90 | -1.19 | -2.61 | -1.83 |
| Korsana Biosciences, Inc. (KRSA)vs › | $148.73M | -12.04 | -8.05 | -55.02 | -123.25 |
| Voyager Therapeutics, Inc. (VYGR)vs › | $148.64M | -1.81 | -1.58 | -0.32 | -0.34 |
| Anavex Life Sciences Corp. (AVXL)vs › | $148.27M | -0.26 | -0.53 | -0.57 | -0.55 |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $146.62M | -1.64 | -1.85 | -1.46 | -1.46 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
